Holding/activity history for Halozyme Therapeutics (HALO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 55,258 | 0.44 | Add 8.89% | 0.04 | $57.24 |
| 2024 Q2 | 50,748 | 0.40 | Add 6.67% | 0.03 | $52.36 |
| 2024 Q1 | 47,573 | 0.29 | Add 19.27% | 0.05 | $40.67 |
| 2023 Q4 | 39,886 | 0.24 | Add 53.38% | 0.08 | $36.96 |
| 2023 Q3 | 26,005 | 0.18 | Add 4.19% | 0.01 | $38.18 |
| 2023 Q2 | 24,959 | 0.16 | Add 0.99% | 0.00 | $36.06 |
| 2023 Q1 | 24,714 | 0.17 | Reduce 21.53% | 0.05 | $38.20 |
| 2022 Q4 | 31,495 | 0.32 | Reduce 4.31% | 0.01 | $56.90 |
| 2022 Q3 | 32,913 | 0.26 | Add 16.33% | 0.04 | $39.53 |
| 2022 Q2 | 28,293 | 0.24 | Reduce 25.19% | 0.08 | $44.00 |
| 2022 Q1 | 37,820 | 0.24 | Add 5.50% | 0.01 | $39.87 |
| 2021 Q4 | 35,850 | 0.21 | Reduce 23.18% | 0.06 | $40.22 |
| 2021 Q3 | 46,669 | 0.29 | Add 1.27% | 0.00 | $40.67 |
| 2021 Q2 | 46,086 | 0.31 | Reduce 1.05% | 0.00 | $45.42 |
| 2021 Q1 | 46,574 | 0.30 | Reduce 1.38% | 0.00 | $41.70 |
| 2020 Q4 | 47,226 | 0.33 | Add 1.02% | 0.00 | $42.71 |
| 2020 Q3 | 46,750 | 0.23 | Reduce 0.69% | 0.00 | $26.29 |
| 2020 Q2 | 47,074 | 0.24 | Reduce 9.60% | 0.03 | $26.81 |
| 2020 Q1 | 52,073 | 0.21 | Add 0.46% | 0.00 | $17.99 |
| 2019 Q4 | 51,832 | 0.16 | Add 11.82% | 0.02 | $17.73 |
| 2019 Q3 | 46,353 | 0.08 | Add 0.24% | 0.00 | $15.51 |
| 2019 Q2 | 46,243 | 0.08 | Reduce 10.77% | 0.01 | $17.17 |
| 2019 Q1 | 51,827 | 0.09 | $16.09 | ||
| 2018 Q4 | 51,827 | 0.09 | Add 18.12% | 0.01 | $14.63 |
| 2018 Q3 | 43,876 | 0.08 | $18.16 |